Table 6. Aqueous cytokines of angle closure eyes in published literatures.
| Patient/control | Method | Different cytokine | Literature |
|---|---|---|---|
| APAC/PACS | Multiplex bead immunoassay | G-CSF, IL-6, IL-8, MCP-1, MCP-3, MDC, MIP-1β, VEGF↑ | Du S, 2016 |
| APAC/cataract | Multiplex bead immunoassay | IL-6, IL-8, G-CSF, MCP-1, MCP-3, VEGF↑ | Huang W, 2014 |
| APAC/cataract | Magnetic bead immunoassay, ELISA | sCD44 and VEGF↑ | Chen S, 2015 |
| APAC/cataract | Cytometric bead assay system | IL-2, IL-5, MCP-1, TNF-α, IP-10↑ | Tong Y, 2017 |
| APAC/cataract | Multiplex bead immunoassay | IL-12, IL-15, IL-6, IL-27↑ | Liu YM, 2017 |
| APAC/PACG | Multiplex bead immunoassay | MCP-1, MCP-3↑ | Gao X, 2016 |
| PACG/cataract | Multiplexed cytokine analysis | IL-8, CXCL9↑ | Chua J, 2012 |
| PACG/cataract | Multiplex bead immunoassay | IL-8, eotaxin, IP-10, MIP-1β↑ IL-9, IL-17, IL-5, TNF-α, GM-CSF↓ | Duvesh R, 2017 |
| PACG/cataract | Cytometric bead assay system | – | Tong Y, 2017 |
| PACG/cataract | Multiplex bead immunoassay | MCP-3, MDC, VEGF↑ MCP-1, MIP-1β↓ | Our study |
Abbreviations: APAC, acute primary angle-closure; PACG, primary angle-closure glaucoma; PACS, primary angle-closure suspect.